A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Aug. 10, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 3, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on...
Single step deployment system increases market potential while reducing install times by 80% Incorporates Enhanced ContraPest Formulation for Improved Performance in the Field PHOENIX, July 24, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"),...
During this fireside chat, we welcome SenesTech, ticker symbol of SNES on the NASDAQ, and their CEO, Joel Fruendt. SenesTech is committed to improving the health of our world by humanely managing animal populations through fertility control. This Fireside Chat was...
PHOENIX, May 15, 2023 -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a...
E-Commerce Leads Growth at 54% Year Over Year PHOENIX, May 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 4, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on...
Growth in the Animal Care Segment of Pest Control Continues to Be Strong PHOENIX, April 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
PHOENIX, March 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, were featured in TIME...
Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, March 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for...
PHOENIX, Feb. 28, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that...
PHOENIX, Feb. 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the...
We are the experts in rat fertility control. Our passion is to create a healthy environment by better controlling rat pest populations. We keep an inescapable truth in mind. Two rats and their descendants can be responsible for the birth of up to 15,000 pups after a...
PHOENIX, Jan. 24, 2023 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today announced the management team will present and host one-on-one meetings with investors at...
PHOENIX, Dec. 20, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the grant...
PHOENIX, Nov. 18, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
PHOENIX, Nov. 16, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
Common Stock Will Begin Trading on a Split-Adjusted Basis on November 16, 2022 PHOENIX, Nov. 15, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
Product Sales up 57% year-over-year PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats,...
PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
Financial results to be released before market open; Conference call to be conducted at 11:00 am ET PHOENIX, Nov. 9, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2022, ended September 30, 2022, before the market open on...
Today we welcome SenesTech, ticker of SNES on the NASDAQ, and their Chief Executive Officer, Ken Siegel; and Chief Financial Officer, Tom Chesterman. SenesTech is the leader in fertility control to manage animal pest populations This Fireside Chat was recorded during...
PHOENIX, Sept. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Fall 2022 Investor Conference taking...
Intended to Facilitate a Reverse Stock Split, if Necessary PHOENIX, Aug. 26, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male...
Sales up 73% year-over-year and up 42% sequentially PHOENIX, Aug. 11, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and...
PHOENIX, Aug. 11, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest, today released further...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 4, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2022, ended June 30, 2022, after the market close on...
PHOENIX, Aug. 1, 2022 -- SenesTech, Inc., (SNES), the rodent fertility control experts, announced that its new Elevate Bait System™ with ContraPest®, the only EPA registered birth control for both male and female rats, is available for sale in all fifty...
"Love is in the air" - a single pair of breeding rats can account for generations of rats; as many as 15,000 after just one year. ContraPest, the EPA-registered birth control for rats, can now be deployed in elevated indoor spaces to combat rising roof rat populations...
Sales up 122% Company Launches New Elevate Bait System™ with ContraPest® PHOENIX, May 12, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 5, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2022, ended March 31, 2022, after the market close on...
SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. We are experts in fertility control to manage animal pest populations. We invented ContraPest, the only U.S. EPA-registered...
PHOENIX, March 31, 2022 -- SenesTech, Inc. (NASDAQ: SNES) announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. The Company's webcast presentation will be available for viewing...
Product Sales up 123% as the Company Drives ContraPest® Deployment in New and Existing Market Verticals PHOENIX, March 29, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, March 23, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2021, ended December 31, 2021, after the...
The Elevate Bait System with ContraPest is specifically designed to address rat problems in above-ground locations. PHOENIX, March 22, 2022 -- SenesTech, Inc., (SNES) announced today the EPA approval of and launch of its newest product design and application, the...
ContraPest®, the one and only EPA approved birth control product for rats, addresses the unique challenges controlling rat populations in this unique customer segment.PHOENIX, Feb. 24, 2022 -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com), the rodent...
Latest in a growing number of deployments in the zoo and animal sanctuary market. ContraPest®, the one and only EPA approved birth control product for rats, addresses the unique challenges controlling rat populations in animal settings.PHOENIX, Feb. 3, 2022 --...
PHOENIX, Jan. 25, 2022 -- SenesTech (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert, announced today that Columbus, Ohio is the latest city to begin using ContraPest®. Columbus now joins cities like San Francisco, Washington DC, Hartford,...
SenesTech's ContraPest® is the only EPA registered fertility control product for ratsPHOENIX, Jan. 21, 2022 -- SenesTech (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert, noted today that Los Angeles County, one of the largest counties in...
During this fireside chat, we welcome SenesTech, ticker symbol of SNES on the NASDAQ and their Chief Executive Officer, Mr. Ken Siegel; and Chief Financial Officer, Tom Chesterman. SenesTech is the leader in fertility control to manage animal pest population. This...
PHOENIX, Dec. 6, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking...
Revenue More Than Doubles from the Third Quarter in 2020 and up 14% SequentiallyPHOENIX, Nov. 10, 2021 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ETPHOENIX, Nov. 3, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will...
ContraPest® is the First and Only EPA Approved Birth Control for Rats.Without fertility control, two base rats, a male and a female, can produce generations of rats, resulting in more than 15 thousand rats in just one year. ContraPest® is an Effective and...
PHOENIX, Sept. 30, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday,...
Revenue Growth of 125% from the Second Quarter in 2020 and 82% SequentiallyPHOENIX, Aug. 12, 2021 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA...
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ETPHOENIX, Aug. 3, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will...
PHOENIX, June 11, 2021 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Tuesday,...
Revenues Up 138 Percent from the First Quarter in 2020PHOENIX, May 13, 2021 -- SenesTech, Inc. (NASDAQ: SNES), (www.senestech.com) the rodent fertility control experts and inventors of the first and only registered rat contraceptive, ContraPest® announced today...